These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 1438191)

  • 1. Complement activation by beta-amyloid in Alzheimer disease.
    Rogers J; Cooper NR; Webster S; Schultz J; McGeer PL; Styren SD; Civin WH; Brachova L; Bradt B; Ward P
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10016-20. PubMed ID: 1438191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide.
    Webster S; Bonnell B; Rogers J
    Am J Pathol; 1997 May; 150(5):1531-6. PubMed ID: 9137079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner.
    Bergamaschini L; Canziani S; Bottasso B; Cugno M; Braidotti P; Agostoni A
    Clin Exp Immunol; 1999 Mar; 115(3):526-33. PubMed ID: 10193429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting the formation of classical C3-convertase on the Alzheimer's beta-amyloid peptide.
    Emmerling MR; Spiegel K; Watson MD
    Immunopharmacology; 1997 Dec; 38(1-2):101-9. PubMed ID: 9476121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: complement activation and therapeutic approaches.
    Chen S; Frederickson RC; Brunden KR
    Neurobiol Aging; 1996; 17(5):781-7. PubMed ID: 8892352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the classical complement pathway in brain tissue of Alzheimer patients.
    McGeer PL; Akiyama H; Itagaki S; McGeer EG
    Neurosci Lett; 1989 Dec; 107(1-3):341-6. PubMed ID: 2559373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-amyloid fibrils activate the C1 complex of complement under physiological conditions: evidence for a binding site for A beta on the C1q globular regions.
    Tacnet-Delorme P; Chevallier S; Arlaud GJ
    J Immunol; 2001 Dec; 167(11):6374-81. PubMed ID: 11714802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation and beta-amyloid-mediated neurotoxicity in Alzheimer's disease.
    Rogers J; Schultz J; Brachova L; Lue LF; Webster S; Bradt B; Cooper NR; Moss DE
    Res Immunol; 1992; 143(6):624-30. PubMed ID: 1455054
    [No Abstract]   [Full Text] [Related]  

  • 9. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.
    Jiang H; Burdick D; Glabe CG; Cotman CW; Tenner AJ
    J Immunol; 1994 May; 152(10):5050-9. PubMed ID: 8176223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation by neurofibrillary tangles in Alzheimer's disease.
    Shen Y; Lue L; Yang L; Roher A; Kuo Y; Strohmeyer R; Goux WJ; Lee V; Johnson GV; Webster SD; Cooper NR; Bradt B; Rogers J
    Neurosci Lett; 2001 Jun; 305(3):165-8. PubMed ID: 11403931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
    Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
    Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of C1q-beta-amyloid binding protects hippocampal cells against complement mediated toxicity.
    Sárvári M; Vágó I; Wéber CS; Nagy J; Gál P; Mák M; Kósa JP; Závodszky P; Pázmány T
    J Neuroimmunol; 2003 Apr; 137(1-2):12-8. PubMed ID: 12667643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-β neurotoxicity.
    Benoit ME; Hernandez MX; Dinh ML; Benavente F; Vasquez O; Tenner AJ
    J Biol Chem; 2013 Jan; 288(1):654-65. PubMed ID: 23150673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
    Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mouse C1q A-chain sequence alters beta-amyloid-induced complement activation.
    Webster SD; Tenner AJ; Poulos TL; Cribbs DH
    Neurobiol Aging; 1999; 20(3):297-304. PubMed ID: 10588577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization and cell association of C1q in Alzheimer's disease brain.
    Afagh A; Cummings BJ; Cribbs DH; Cotman CW; Tenner AJ
    Exp Neurol; 1996 Mar; 138(1):22-32. PubMed ID: 8593893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association cortex, cerebellum, and serum concentrations of C1q and factor B in Alzheimer's disease.
    Brachova L; Lue LF; Schultz J; el Rashidy T; Rogers J
    Brain Res Mol Brain Res; 1993 Jun; 18(4):329-34. PubMed ID: 8326828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of complement and contact system in Alzheimer's disease.
    Bergamaschini L; Donarini C; Gobbo G; Parnetti L; Gallai V
    Mech Ageing Dev; 2001 Nov; 122(16):1971-83. PubMed ID: 11589915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivalent binding of complement protein C1Q to the amyloid beta-peptide (A beta) promotes the nucleation phase of A beta aggregation.
    Webster S; Glabe C; Rogers J
    Biochem Biophys Res Commun; 1995 Dec; 217(3):869-75. PubMed ID: 8554610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein.
    Gronemus JQ; Hair PS; Crawford KB; Nyalwidhe JO; Cunnion KM; Krishna NK
    Mol Immunol; 2010; 48(1-3):305-13. PubMed ID: 20728940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.